162 related articles for article (PubMed ID: 34844892)
21. POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.
Dispenzieri A
Am J Hematol; 2017 Aug; 92(8):814-829. PubMed ID: 28699668
[TBL] [Abstract][Full Text] [Related]
22. POEMS syndrome: update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2015 Oct; 90(10):951-62. PubMed ID: 26331353
[TBL] [Abstract][Full Text] [Related]
23. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2011 Jul; 86(7):591-601. PubMed ID: 21681783
[TBL] [Abstract][Full Text] [Related]
24. POEMS syndrome: update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2012 Aug; 87(8):804-14. PubMed ID: 22806697
[TBL] [Abstract][Full Text] [Related]
25. POEMS neuropathy: optimising diagnosis and management.
Keddie S; D'Sa S; Foldes D; Carr AS; Reilly MM; Lunn MPT
Pract Neurol; 2018 Aug; 18(4):278-290. PubMed ID: 29511110
[TBL] [Abstract][Full Text] [Related]
26. POEMS syndrome: A multisystem clonal disorder.
Ali T; Qazilbash MH
Eur J Haematol; 2021 Jan; 106(1):14-18. PubMed ID: 32889731
[TBL] [Abstract][Full Text] [Related]
27. POEMS syndrome: experience with fourteen cases.
Singh D; Wadhwa J; Kumar L; Raina V; Agarwal A; Kochupillai V
Leuk Lymphoma; 2003 Oct; 44(10):1749-52. PubMed ID: 14692529
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients.
Fang F; Lan XX; Hu RH; Hui WH; Zhao H; Guo YX; Ji BX; Liu HJ; Su L; Sun WL
Ther Adv Neurol Disord; 2024; 17():17562864231219151. PubMed ID: 38288324
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
30. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2014 Feb; 89(2):214-23. PubMed ID: 24532337
[TBL] [Abstract][Full Text] [Related]
31. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation.
Rovira M; Carreras E; Bladé J; Graus F; Valls J; Fernández-Avilés F; Montserrat E
Br J Haematol; 2001 Nov; 115(2):373-5. PubMed ID: 11703338
[TBL] [Abstract][Full Text] [Related]
32. POEMS syndrome: radiographic appearance with MRI correlation.
Chong ST; Beasley HS; Daffner RH
Skeletal Radiol; 2006 Sep; 35(9):690-5. PubMed ID: 16247640
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy.
Imai N; Kitamura E; Tachibana T; Konishi T; Suzuki Y; Serizawa M; Okabe T; Fujita H
Intern Med; 2007; 46(3):135-8. PubMed ID: 17268130
[TBL] [Abstract][Full Text] [Related]
34. Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma.
Xu J; Wang Q; Xu H; Gu C; Jiang L; Wang J; Wang D; Xu B; Mao X; Wang J; Wang Z; Xiao Y; Zhang Y; Li C; Zhou J
J Hematol Oncol; 2018 Oct; 11(1):128. PubMed ID: 30348186
[TBL] [Abstract][Full Text] [Related]
35. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
Cook G; Iacobelli S; van Biezen A; Ziagkos D; LeBlond V; Abraham J; McQuaker G; Schoenland S; Rambaldi A; Halaburda K; Rovira M; Sica S; Byrne J; Sanz RG; Nagler A; van de Donk NW; Sinisalo M; Cook M; Kröger N; De Witte T; Morris C; Garderet L
Haematologica; 2017 Jan; 102(1):160-167. PubMed ID: 27634201
[TBL] [Abstract][Full Text] [Related]
36. A review of POEMS syndrome.
Dispenzieri A; Buadi FK
Oncology (Williston Park); 2013 Dec; 27(12):1242-50. PubMed ID: 24624542
[TBL] [Abstract][Full Text] [Related]
37. [A man with plasma cell dyscrasia and polyneuropathy due to POEMS syndrome].
Driessens SK; Wildiers H; Verhoef GE; Vanstraelen D; Robberecht W; Vandenberghe P
Ned Tijdschr Geneeskd; 2002 Feb; 146(7):321-5. PubMed ID: 11876037
[TBL] [Abstract][Full Text] [Related]
38. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
39. POEMS Syndrome: Bone Marrow, Laboratory, and Clinical Findings in 24 Korean Patients.
Shim H; Seol CA; Park CJ; Cho YU; Seo EJ; Lee JH; Yoon DH; Suh CW; Park SH; Jang S
Ann Lab Med; 2019 Nov; 39(6):561-565. PubMed ID: 31240884
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Keddie S; Foldes D; Caimari F; Baldeweg SE; Bomsztyk J; Ziff OJ; Fehmi J; Cerner A; Jaunmuktane Z; Brandner S; Yong K; Manji H; Carr A; Rinaldi S; Reilly MM; D'Sa S; Lunn MP
Neurology; 2020 Jul; 95(3):e268-e279. PubMed ID: 32606227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
